Puma Biotech Gets Favorable FDA Vote On Neratinib – Benzinga


Investor's Business Daily
Puma Biotech Gets Favorable FDA Vote On Neratinib
Benzinga
Puma Biotechnology Inc (NASDAQ: PBYI) traders are eagerly-anticipating the end of the trading halt for Puma on Wednesday after the company received a positive recommendation for approval of neratinib from the FDA's Oncologic Drugs Advisory ...
US FDA panel backs Puma Biotech's breast cancer drugReuters
This Biotech Stock Has Soared 84% This Week On Breast-Cancer Drug NewsInvestor's Business Daily
Puma Biotechnology FDA Live BlogForbes
MarketWatch -Markets Insider -Nasdaq
all 73 news articles »

Read More